IGSF8 expression differentially modifies response to immunotherapy in metastatic melanoma

IGSF8 identified as novel immune checkpoint modifying IO outcomes stratified by Tempus IPS

INDICATION
Melanoma
BIOMARKER
IGSF8

Related cases

Abstract pattern of varying density purple dots on a white grid background.

LAG3 expression as a predictive biomarker for 1L ICI in melanoma

2025-10-09
Melanoma
LAG3
Unable to determine image content.

Characterizing CLDN18.2 and HER2 expression in gastroesophageal cancer

2026-03-27
Gastric
CLDN18.2
Abstract grid of blue and black fading square pixels on a white background.

Developing a gene expression signature for first-line treatment in metastatic CRC

2026-03-27
Colorectal